PRTG logo

Portage Biotech (PRTG) Free Cash Flow

Annual FCF

-$14.30 M
-$2.22 M-18.39%

March 31, 2024


Summary


Performance

PRTG Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRTGcash flowmetrics:

Quarterly FCF

-$1.56 M
+$126.00 K+7.47%

September 30, 2024


Summary


Performance

PRTG Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRTGcash flowmetrics:

TTM FCF

-$9.80 M
+$2.73 M+21.80%

September 30, 2024


Summary


Performance

PRTG TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRTGcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

PRTG Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.4%0.0%0.0%
3 y3 years-233.7%+30.7%-44.9%
5 y5 years-1566.3%-25.5%-132.8%

PRTG Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-233.7%at lowat high+66.7%-80.4%+38.2%
5 y5-year-1566.3%at low-140.0%+66.7%-201.1%+38.2%
alltimeall time-9632.5%at low-150.1%+68.4%-434.3%+38.2%

Portage Biotech Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.56 M(-7.5%)
-$9.80 M(-21.8%)
Jun 2024
-
-$1.69 M(-46.0%)
-$12.53 M(-12.4%)
Mar 2024
-$14.30 M(+18.4%)
-$3.12 M(-9.0%)
-$14.30 M(-9.8%)
Dec 2023
-
-$3.43 M(-20.1%)
-$15.86 M(+4.8%)
Sep 2023
-
-$4.29 M(+24.3%)
-$15.13 M(+13.3%)
Jun 2023
-
-$3.45 M(-26.2%)
-$13.35 M(+10.6%)
Mar 2023
-$12.08 M(+78.5%)
-$4.68 M(+73.1%)
-$12.08 M(+25.2%)
Dec 2022
-
-$2.70 M(+7.5%)
-$9.65 M(+12.2%)
Sep 2022
-
-$2.52 M(+15.6%)
-$8.60 M(+16.8%)
Jun 2022
-
-$2.18 M(-3.3%)
-$7.36 M(+8.8%)
Mar 2022
-$6.76 M(+57.9%)
-$2.25 M(+35.8%)
-$6.76 M(+24.6%)
Dec 2021
-
-$1.66 M(+30.0%)
-$5.43 M(+18.9%)
Sep 2021
-
-$1.27 M(-19.3%)
-$4.57 M(-11.8%)
Jun 2021
-
-$1.58 M(+72.3%)
-$5.18 M(+20.8%)
Mar 2021
-$4.28 M(+15.3%)
-$917.00 K(+15.5%)
-$4.28 M(+1.8%)
Dec 2020
-
-$794.00 K(-57.9%)
-$4.21 M(+3.5%)
Sep 2020
-
-$1.89 M(+174.0%)
-$4.07 M(+18.8%)
Jun 2020
-
-$688.00 K(-18.3%)
-$3.42 M(-7.8%)
Mar 2020
-$3.71 M(+332.9%)
-$842.00 K(+29.5%)
-$3.71 M(+14.1%)
Dec 2019
-
-$650.00 K(-47.7%)
-$3.25 M(+20.2%)
Sep 2019
-
-$1.24 M(+27.0%)
-$2.71 M(+63.9%)
Jun 2019
-
-$979.00 K(+156.3%)
-$1.65 M(+92.5%)
Mar 2019
-$858.00 K(-20.0%)
-$382.00 K(+267.3%)
-$858.00 K(+24.7%)
Dec 2018
-
-$104.00 K(-44.4%)
-$688.00 K(-27.3%)
Sep 2018
-
-$187.00 K(+1.1%)
-$947.00 K(-6.3%)
Jun 2018
-
-$185.00 K(-12.7%)
-$1.01 M(-5.8%)
Mar 2018
-$1.07 M(-18.8%)
-$212.00 K(-41.6%)
-$1.07 M(-147.6%)
Dec 2017
-
-$363.00 K(+44.6%)
$2.25 M(-6.1%)
Sep 2017
-
-$251.00 K(+1.6%)
$2.40 M(-5.8%)
Jun 2017
-
-$247.00 K(-107.9%)
$2.55 M(-293.0%)
Mar 2017
-$1.32 M(-80.7%)
$3.12 M(-1542.6%)
-$1.32 M(-76.8%)
Dec 2016
-
-$216.00 K(+107.5%)
-$5.69 M(-17.0%)
Sep 2016
-
-$104.10 K(-97.5%)
-$6.85 M(-32.0%)
Jun 2016
-
-$4.12 M(+229.4%)
-$10.07 M(+47.2%)
Mar 2016
-$6.84 M(+161.6%)
-$1.25 M(-9.5%)
-$6.84 M(+3.7%)
Dec 2015
-
-$1.38 M(-58.4%)
-$6.60 M(+16.6%)
Sep 2015
-
-$3.32 M(+275.1%)
-$5.66 M(+81.4%)
Jun 2015
-
-$885.90 K(-12.1%)
-$3.12 M(+19.3%)
Mar 2015
-$2.61 M(+35.1%)
-$1.01 M(+129.4%)
-$2.61 M(-6.2%)
Dec 2014
-
-$439.20 K(-44.0%)
-$2.79 M(+8.4%)
Sep 2014
-
-$784.60 K(+105.2%)
-$2.57 M(+22.5%)
Jun 2014
-
-$382.30 K(-67.6%)
-$2.10 M(+8.4%)
Mar 2014
-$1.94 M(+8.0%)
-$1.18 M(+429.3%)
-$1.94 M(-348.2%)
Dec 2013
-
-$223.00 K(-28.6%)
$779.70 K(+16.6%)
Sep 2013
-
-$312.40 K(+42.3%)
$668.60 K(-77.2%)
Jun 2013
-
-$219.60 K(-114.3%)
$2.93 M(-263.5%)
Mar 2013
-$1.79 M
$1.53 M(-559.4%)
-$1.79 M(-49.8%)
Dec 2012
-
-$334.10 K(-117.1%)
-$3.57 M(+1.7%)
DateAnnualQuarterlyTTM
Sep 2012
-
$1.95 M(-139.4%)
-$3.52 M(-39.1%)
Jun 2012
-
-$4.94 M(+1905.2%)
-$5.77 M(+330.9%)
Mar 2012
-$1.34 M(-49.0%)
-$246.50 K(-10.7%)
-$1.34 M(+35.5%)
Dec 2011
-
-$275.90 K(-10.5%)
-$989.00 K(-16.0%)
Sep 2011
-
-$308.20 K(-39.5%)
-$1.18 M(+11.8%)
Jun 2011
-
-$509.40 K(-587.5%)
-$1.05 M(-59.9%)
Mar 2011
-$2.63 M(-47.0%)
$104.50 K(-122.5%)
-$2.63 M(-31.3%)
Dec 2010
-
-$463.70 K(+152.1%)
-$3.82 M(-43.9%)
Sep 2010
-
-$183.90 K(-91.2%)
-$6.82 M(-1.9%)
Jun 2010
-
-$2.08 M(+90.7%)
-$6.95 M(+40.1%)
Mar 2010
-$4.96 M(+1601.8%)
-$1.09 M(-68.4%)
-$4.96 M(+25.7%)
Dec 2009
-
-$3.46 M(+1006.0%)
-$3.95 M(+696.4%)
Sep 2009
-
-$312.70 K(+222.7%)
-$495.50 K(+74.4%)
Jun 2009
-
-$96.90 K(+24.2%)
-$284.10 K(-2.5%)
Mar 2009
-$291.50 K(-38.7%)
-$78.00 K(+887.3%)
-$291.50 K(+6.3%)
Dec 2008
-
-$7900.00(-92.2%)
-$274.20 K(-24.4%)
Sep 2008
-
-$101.30 K(-2.9%)
-$362.60 K(-10.9%)
Jun 2008
-
-$104.30 K(+71.8%)
-$406.80 K(-14.5%)
Mar 2008
-$475.70 K(+2.9%)
-$60.70 K(-37.0%)
-$475.70 K(-23.4%)
Dec 2007
-
-$96.30 K(-33.8%)
-$621.10 K(+28.8%)
Sep 2007
-
-$145.50 K(-16.0%)
-$482.40 K(+47.2%)
Jun 2007
-
-$173.20 K(-16.0%)
-$327.70 K(-29.1%)
Mar 2007
-$462.40 K(-87.8%)
-$206.10 K(-586.1%)
-$462.50 K(+578.2%)
Dec 2006
-
$42.40 K(+360.9%)
-$68.20 K(+180.7%)
Sep 2006
-
$9200.00(-103.0%)
-$24.30 K(-99.3%)
Jun 2006
-
-$308.00 K(-263.7%)
-$3.44 M(-9.3%)
Mar 2006
-$3.79 M(+1077.8%)
$188.20 K(+118.1%)
-$3.79 M(-4.7%)
Dec 2005
-
$86.30 K(-102.5%)
-$3.97 M(-34.6%)
Sep 2005
-
-$3.40 M(+416.7%)
-$6.08 M(+113.6%)
Jun 2005
-
-$658.50 K(-67.3%)
-$2.84 M(+2.1%)
Dec 2004
-
-$2.01 M(+1074.5%)
-$2.79 M(-634.1%)
Sep 2004
-
-$171.50 K(-50.7%)
$521.80 K(-179.8%)
Jun 2004
-
-$348.20 K(+37.6%)
-$654.20 K(+103.5%)
Mar 2004
-$321.50 K(+118.9%)
-$253.00 K(-119.5%)
-$321.50 K(+344.1%)
Dec 2003
-
$1.29 M(-196.1%)
-$72.40 K(-94.9%)
Sep 2003
-
-$1.35 M(+8593.5%)
-$1.42 M(+1130.6%)
Jun 2003
-
-$15.50 K(+297.4%)
-$115.20 K(-21.5%)
Mar 2003
-$146.90 K(-6.4%)
-$3900.00(-92.3%)
-$146.80 K(-37.7%)
Dec 2002
-
-$50.80 K(+12.9%)
-$235.70 K(-0.8%)
Sep 2002
-
-$45.00 K(-4.5%)
-$237.60 K(+25.4%)
Jun 2002
-
-$47.10 K(-49.2%)
-$189.50 K(+20.7%)
Mar 2002
-$157.00 K(-56.2%)
-$92.80 K(+76.1%)
-$157.00 K(+144.5%)
Dec 2001
-
-$52.70 K(-1800.0%)
-$64.20 K(+458.3%)
Sep 2001
-
$3100.00(-121.2%)
-$11.50 K(-21.2%)
Jun 2001
-
-$14.60 K
-$14.60 K
Mar 2001
-$358.30 K(-17.8%)
-
-
Mar 2000
-$435.70 K(+21.4%)
-
-
Mar 1999
-$359.00 K(-15.3%)
-
-
Mar 1998
-$423.80 K
-
-

FAQ

  • What is Portage Biotech annual free cash flow?
  • What is the all time high annual FCF for Portage Biotech?
  • What is Portage Biotech annual FCF year-on-year change?
  • What is Portage Biotech quarterly free cash flow?
  • What is the all time high quarterly FCF for Portage Biotech?
  • What is Portage Biotech quarterly FCF year-on-year change?
  • What is Portage Biotech TTM free cash flow?
  • What is the all time high TTM FCF for Portage Biotech?
  • What is Portage Biotech TTM FCF year-on-year change?

What is Portage Biotech annual free cash flow?

The current annual FCF of PRTG is -$14.30 M

What is the all time high annual FCF for Portage Biotech?

Portage Biotech all-time high annual free cash flow is -$146.90 K

What is Portage Biotech annual FCF year-on-year change?

Over the past year, PRTG annual free cash flow has changed by -$2.22 M (-18.39%)

What is Portage Biotech quarterly free cash flow?

The current quarterly FCF of PRTG is -$1.56 M

What is the all time high quarterly FCF for Portage Biotech?

Portage Biotech all-time high quarterly free cash flow is $3.12 M

What is Portage Biotech quarterly FCF year-on-year change?

Over the past year, PRTG quarterly free cash flow has changed by $0.00 (0.00%)

What is Portage Biotech TTM free cash flow?

The current TTM FCF of PRTG is -$9.80 M

What is the all time high TTM FCF for Portage Biotech?

Portage Biotech all-time high TTM free cash flow is $2.93 M

What is Portage Biotech TTM FCF year-on-year change?

Over the past year, PRTG TTM free cash flow has changed by $0.00 (0.00%)